Teitur Trophics
Teitur Trophics is a biotech company developing novel treatments for neurodegenerative diseases.
Operating in biotechnology, life science, medical based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), Teitur Trophics was founded in 2020.
Within the biotechnology, life science, medical space, the company focuses on its core offering rather than a broad product line.
European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) is where the company is located.
It is recorded at the Series_A stage.
The company reports a headcount in the c_00001_00010 range.
Total disclosed funding stands at about $28M.
| Sector | Biotechnology, Life Science, Medical |
|---|---|
| Headquarters | European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2020 |
| Employees | c_00001_00010 |
| Stage | series_a |
| Total funding | $28,000,000 |
Website: teiturtrophics.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account